Abstract
This Frost & Sullivan research service entitled U.S. Congestive Heart Failure
Device Markets provides an overview of alternate treatment options in the U.S.
markets for the treatment of CHF along with a complete analysis of key market
drivers, restraints, and trends. In this research service, Frost & Sullivan' s
expert analysts thoroughly examine the U.S cardiac resynchronization therapy
(CRT) and ventricular assist devices (VAD) markets.
View Cart
